![]() |
#1 |
![]() |
|
![]() |
![]() |
![]() |
#2 |
![]() 4- 4 : 1 - IV , , HER2 BRCA . 2- , . . ( ), . , , |
|
![]() |
![]() |
![]() |
#3 |
![]() 4- 4 ( 1. HER2-, () 4 , BRCA-1 BRCA-2 . 1-, 2-, 3- , / 1-, 2- 30 . ++ . 2. , (T3-4, N 0-3 T1-2, N 2-3 ) 4 , , 1 2 , / . ≤ 12. 3 . (). 3 ( ER-, PR-, HER2/ neu-(1+)), . -, . . . ( ), . , , |
|
![]() |
![]() |
![]() |
#4 |
![]() 4- 4 1. HER2-, () 4 , BRCA-1 BRCA-2 . 1-, 2-, 3- , / 1-, 2- 30 . ++ . 2. , (T3-4, N 0-3 T1-2, N 2-3 ) 4 , , 1 2 , / . ≤ 12. 3 . (). 3. - - . PDL. +. 4. , 2-4, 365 . ++ . ( ), . , , |
|
![]() |
![]() |
![]() |
#5 |
![]()
, , , -.
|
|
![]() |
![]() |
![]() |
#6 |
![]()
4 - 8 , (9 ), 31. , , , , .
youtube , facebook - , +38 067 633 19 75, +38 068 903 03 03. , , - |
|
![]() |
![]() |
![]() |
#7 |
![]()
, . , ,
|
|
![]() |
![]() |
![]() |
#8 |
![]()
:
|
|
![]() |
![]() |
![]() |
#9 |
![]()
100% , ... !!!
|
|
![]() |
![]() |